| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mira Pharmaceuticals, Inc. (MIRA) has 2 insiders with recent SEC Form 4 filings, including 10 buys and 25 sells. MIRA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.53M | $3.74M | - | |
| Dir | 22.4K | $23.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | Aminov Erez | Chief Executive Officer | Sell | 100,000 | $1.34 | $133,649.20 | -4.4% | |
| Aug 28, 2024 | McNulty Brian Patrick | 10% Owner | Sell | 200,000 | $1.96 | $392,000.00 | -7.3% | |
| May 21, 2024 | Aminov Erez | Chief Executive Officer | Buy | 8,700 | $0.94 | $8,176.00 | +0.3% | |
| Dec 11, 2023 | McNulty Brian Patrick | - | Sell | 238,095 | $3.05 | $726,087.98 | -0.6% | |
| Aug 7, 2023 | Cappy George | - | Buy | 119,048 | $7.00 | $833,336.00 | +4.3% | |
| Aug 2, 2023 | Cappy George | - | Buy | 157,170 | $7.00 | $1,100,190.00 | +6.1% |